Literature DB >> 26420890

ReCAP: Gaps in Insurance Coverage for Pediatric Patients With Acute Lymphoblastic Leukemia.

Rochelle R Smits-Seemann1, Sapna Kaul2, Aimee O Hersh2, Mark N Fluchel2, Kenneth M Boucher2, Anne C Kirchhoff2, Rochelle R Smits-Seemann1, Sapna Kaul2, Aimee O Hersh2, Mark N Fluchel2, Kenneth M Boucher2, Anne C Kirchhoff2.   

Abstract

PURPOSE: Continuous insurance coverage is an important component of effective health care. Evaluation of insurance gaps in pediatric cancer care is an understudied area.
METHODS: We conducted a retrospective analysis of payer data from outpatient oncology encounters at Primary Children's Hospital (Salt Lake City, UT) over the first 2 years of therapy for pediatric patients with acute lymphoblastic leukemia diagnosed from 1998 to 2010 (N = 380). Using logistic regression, we evaluated demographic and clinical predictors (age at diagnosis, sex, ethnicity, high/standard acute lymphoblastic leukemia risk, and rural/urban county of residence at diagnosis) of a gap in health insurance.
RESULTS: The median age at diagnosis was 4 years (interquartile range, 3 to 8 years), and 172 patients (45%) were girls. In the first 2 years of treatment, 45 patients (12%) experienced a gap in health insurance. The odds of having a gap in insurance coverage decreased by 16% each year from 1998 to 2010 (odds ratio, 0.84; 95% CI, 0.76 to 0.93; test for trend, P = .001). Public insurance at diagnosis was associated with a four-fold increased likelihood of experiencing an insurance gap (odds ratio, 4.09; 95% CI, 1.98 to 8.44; P < .001) compared with patients with private insurance at diagnosis.
CONCLUSION: Gaps in insurance coverage during pediatric cancer treatment are not uncommon, which highlights the importance of discussing insurance status at diagnosis and throughout a patient's treatment course to help patients and their families prepare for any changes and avoid unnecessary financial burden. Future research should focus on examining the effect of insurance gaps on patient outcomes and evaluating likelihood of gaps in insurance after health care reform.
Copyright © 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 26420890     DOI: 10.1200/JOP.2015.005686

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  4 in total

1.  An investigation of survivorship clinic attendance among childhood cancer survivors living in a five-state rural region.

Authors:  Judy Y Ou; Rochelle R Smits-Seemann; Yelena P Wu; Jennifer Wright; Anne C Kirchhoff
Journal:  J Cancer Surviv       Date:  2017-11-29       Impact factor: 4.442

2.  Risk of hospitalization among survivors of childhood and adolescent acute lymphoblastic leukemia compared to siblings and a general population sample.

Authors:  Judy Y Ou; Rochelle R Smits-Seemann; Sapna Kaul; Mark N Fluchel; Carol Sweeney; Anne C Kirchhoff
Journal:  Cancer Epidemiol       Date:  2017-07-19       Impact factor: 2.984

3.  A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia.

Authors:  Sapna Kaul; Ernest Kent Korgenski; Jian Ying; Christi F Ng; Rochelle R Smits-Seemann; Richard E Nelson; Seth Andrews; Elizabeth Raetz; Mark Fluchel; Richard Lemons; Anne C Kirchhoff
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452

4.  Distance to treatment center is associated with survival in children and young adults with acute lymphoblastic leukemia.

Authors:  Seth J Rotz; Wei Wei; Stefanie M Thomas; Rabi Hanna
Journal:  Cancer       Date:  2020-09-10       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.